Youdim MB - Search Results

1

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.

Unzeta M, Esteban G, Bolea I, Fogel WA, Ramsay RR, Youdim MB, Tipton KF, Marco-Contelles J. Unzeta M, et al. Among authors: youdim mb. Front Neurosci. 2016 May 25;10:205. doi: 10.3389/fnins.2016.00205. eCollection 2016. Front Neurosci. 2016. PMID: 27252617 Free PMC article. Review.

2

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease.

Youdim MB, Tipton KF. Youdim MB, et al. Parkinsonism Relat Disord. 2002 Mar;8(4):247-53. doi: 10.1016/s1353-8020(01)00011-6. Parkinsonism Relat Disord. 2002. PMID: 12039419

3

The therapeutic potential of monoamine oxidase inhibitors.

Youdim MB, Edmondson D, Tipton KF. Youdim MB, et al. Nat Rev Neurosci. 2006 Apr;7(4):295-309. doi: 10.1038/nrn1883. Nat Rev Neurosci. 2006. PMID: 16552415 Review.

4

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.

Wang L, Esteban G, Ojima M, Bautista-Aguilera OM, Inokuchi T, Moraleda I, Iriepa I, Samadi A, Youdim MB, Romero A, Soriano E, Herrero R, Fernández Fernández AP, Ricardo-Martínez-Murillo, Marco-Contelles J, Unzeta M. Wang L, et al. Among authors: youdim mb. Eur J Med Chem. 2014 Jun 10;80:543-61. doi: 10.1016/j.ejmech.2014.04.078. Epub 2014 Apr 29. Eur J Med Chem. 2014. PMID: 24813882

5

The interactions of milacemide with monoamine oxidase.

O'Brien EM, Tipton KF, McCrodden JM, Youdim MB. O'Brien EM, et al. Among authors: youdim mb. Biochem Pharmacol. 1994 Feb 11;47(4):617-23. doi: 10.1016/0006-2952(94)90123-6. Biochem Pharmacol. 1994. PMID: 8129740

6

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

Kupershmidt L, Weinreb O, Amit T, Mandel S, Bar-Am O, Youdim MB. Kupershmidt L, et al. Among authors: youdim mb. Neuroscience. 2011 Aug 25;189:345-58. doi: 10.1016/j.neuroscience.2011.03.040. Epub 2011 May 6. Neuroscience. 2011. PMID: 21570450

7

The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.

Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Weinreb O. Kupershmidt L, et al. Among authors: youdim mb. Antioxid Redox Signal. 2012 Sep 15;17(6):860-77. doi: 10.1089/ars.2011.4279. Epub 2012 Apr 17. Antioxid Redox Signal. 2012. PMID: 22360429

8

Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols.

Mandel SA, Weinreb O, Amit T, Youdim MB. Mandel SA, et al. Among authors: youdim mb. Front Biosci (Schol Ed). 2012 Jan 1;4(2):581-98. doi: 10.2741/S286. Front Biosci (Schol Ed). 2012. PMID: 22202078 Free article. Review.

9

Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.

Kupershmidt L, Amit T, Bar-Am O, Weinreb O, Youdim MB. Kupershmidt L, et al. Among authors: youdim mb. Mol Neurobiol. 2012 Aug;46(1):217-20. doi: 10.1007/s12035-012-8304-7. Epub 2012 Jul 31. Mol Neurobiol. 2012. PMID: 22847630

10

The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.

Mechlovich D, Amit T, Bar-Am O, Mandel S, Youdim MB, Weinreb O. Mechlovich D, et al. Among authors: youdim mb. Curr Alzheimer Res. 2014 Feb;11(2):119-27. doi: 10.2174/1567205010666131212112529. Curr Alzheimer Res. 2014. PMID: 24359498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page